Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. [electronic resource]
Producer: 19850729Description: 41-7 p. digitalISSN:- 0008-543X
- Actuarial Analysis
- Adult
- Aged
- Brain Neoplasms -- drug therapy
- Clinical Trials as Topic
- Combined Modality Therapy
- Female
- Glioblastoma -- drug therapy
- Humans
- Lomustine -- adverse effects
- Male
- Middle Aged
- Misonidazole -- adverse effects
- Nitroimidazoles -- therapeutic use
- Radiotherapy Dosage
- Random Allocation
- Scandinavian and Nordic Countries
- Telencephalon -- surgery
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.